In non-metastatic NSCLC, PD-L1 expression on CAFs suggests the induction of anti-tumor immune responses, contributing to better prognosis after surgery and impacting the interaction between tumor cells and the immune system.110. The gene discussed is CD274; the disease is neoplasm.